Doyle Anthony

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Doyle Anthony's trades of BioCryst Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
178.64
Quantity 83,360 -44.1%
Value US$1,144,812
Transaction date
Purchase
Price
479.25
Quantity 27,657 +18.4%
Value US$3,387,503
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-15 2024-05-14
B Purchase
83,360 -44.1%
178.64
US$1,144,812 		83,360 -44.1% 178.64 US$1,144,812
2022-12-19 2022-12-15
PlS Planned sale
30,325 -38.6%
269.78
US$2,863,334 		30,325 -38.6% 269.78 US$2,863,334
2021-11-24 2021-11-23
B Purchase
27,657 +18.4%
479.25
US$3,387,503 		27,657 +18.4% 479.25 US$3,387,503
2020-08-12 2020-08-11
B Purchase
54,000 +inf%
4.08
US$220,320 		54,000 +inf% 4.08 US$220,320